Dr Sahin on the Design of the Northstar Response Assay in Advanced GI Cancer
Ilyas Sahin, MD, discusses the Northstar Response assay and the future of precision oncology in patients with advanced gastrointestinal cancer.
Stay updated with breaking news from Northstar Response. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ilyas Sahin, MD, discusses the Northstar Response assay and the future of precision oncology in patients with advanced gastrointestinal cancer.
Culmination Bio, a data and technology company combining clinical and biospecimen data, announced a partnership with BillionToOne, Inc., a next-generation molecular diagnostics company
Ilyas Sahin, MD, discusses an assessment of the Northstar Response in patients with advanced gastrointestinal cancer undergoing active treatment.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!